Myriad Genetics, Inc. (NASDAQ: MYGN) today announced that its Board is reviewing management's analysis of several strategic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE